Background: The IQVIA Institute for Human Data Science will offer a multi-stakeholder webinar on December 07, 2023 to discuss the direct impacts of diabetes on clinical practices and the economy of health systems. The panel will feature renowned experts who will bring complementary and distinct views on the main impacts and economic consequences of untreated diabetes, in addition to global health considerations, such as access, treatment options, economic opportunities.

This is a non-commercial event hosted by the IQVIA Institute for Human Data Science and is intended to advance understanding among all stakeholders of some of the potential transformative changes on the horizon and their implications for health systems globally.

Participation will be open to the public and free of charge.

Format: The virtual symposium will begin with a 10-minute presentation of highlights from recent research by the IQVIA Institute followed by a moderated discussion among panelists and time for Q&A submitted by the audience.

• John Cawley, Ph.D. Director, Institute on Health Economics, Health Behaviors and Disparities at Cornell University
• Johanna Ralston, CEO, World Obesity Federation
• William Shrank, MD, Venture Partner at Andreessen Horowitz
• John Steele, MSc, VP of Corporate Affairs at Lilly Diabetes and Obesity
• Ken Thorpe, Ph.D., Professor and Chair, Department of Health Policy and Management at Emory University

Moderator: Murray Aitken, Executive Director, IQVIA Institute for Human Data Science

• Economic and health consequences of un(der)treated obesity
• Recent developments in GLP-1 therapeutics and the outlook for these treatments
• Impact on clinical care for patients
• Global health considerations: access, treatment options, economic opportunities